The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12

Viral Immunology

Volumn 13, Issue 1, 2000, Pages 57-72

  Hancock, Gerald E ^a   Smith, Jason D ^a   Heers, Kristen M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 12; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VACCINE PRODUCTION; VIRUS INFECTION;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS;

EID: 0034098957     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2000.13.57     Document Type: Article

References (53)

1. Alwan, W.H., W.J. Kozlowska, and P.J.M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
2. Alwan, W.H., F.J. Record, and P.J.M. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 150:5211-5218.
3. Brideau, R.J., R.R. Walters, M.A. Stier, and M.W. Wathen. 1989. Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. J. Gen. Virol. 70:2637-2644.
4. Brunda, M.J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280-288.
5. Chan S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
6. Chanock, R.M., and R.H. Parrott. 1965. Acute respiratory disease in infancy and childhood: present understanding and prospects for prevention. Pediatrics 36:21-39.
7. Chanock, R.M., R.H. Parrott, M. Connors, P.L. Collins, and B.R. Murphy. 1992. Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. Pediatrics 90:137-143.
8. Cherrie, A.H., K. Anderson, G.W. Wertz, and P.J.M Openshaw. 1992. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J. Virol. 66:2102-2110.
9. Coffman, R.L., B.W.P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308-310.
10. Colby, W.D., and G.H. Strejan. 1980. Immunological tolerance of the mouse IgE system: dissociation between T cell tolerance and suppressor cell activity. Eur. J. Immunol. 10:602-608.
11. Colocho Zelaya, E.A., C. Orvell, and O. Strannegard. 1994. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr. Allergy Immunol. 5:100-106.
12. Connors, M., N.A. Giese, A.B. Kulkarni, C.-Y. Firestone, H.C. Morse, and B.R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:5321-5325.
13. + T cells. J. Virol. 66:7444-7451.
14. Dubois, B., C. Massacrier, B. Vanbervliet, J. Fayette, F. Briere, J. Banchereau, and C. Caux. 1998. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 161:2223-2231.
15. Fernie, B.F., E.C. Ford, and J.L. Gerin. 1981. The development of BALB/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface (41129). Proc. Soc. Exp. Biol. Med. 167:83-86.
16. Finkleman, R.D., J. Holmes, I.M. Katona, J.F.J. Urban, M.P. Beckmann, L.S. Park, K.A. Schooley, R.L. Coffman, T.R. Mosmann, and W.E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
17. Graham, B.S., G.S. Henderson, Y-W Tang, X. Lu, K.M. Neuzil, and D.G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
18. Hall, C.B., E.E. Walsh, C.E. Long, and K.C Schnabel. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:693-698.
19. Han, L.L., J.P. Alexander, and L.J. Anderson. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 179:25-30.
20. Hancock, G.E., D.J. Hahn, D.J. Speelman, S.W. Hildreth, S. Pillai, and K. McQueen. 1994. The pulmonary immune response of BALB/c mice vaccinated with the fusion protein of respiratory syncytial virus. Vaccine 12:267-274.
21. Hancock, G.E., D.J. Speelman, P.J. Frenchick, M.M. Mineo-Kuhn, R.B. Baggs, and D.J. Hahn. 1995. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine 13:391-400.
22. Hancock, G.E., D.J. Speelman, K. Heers, E. Bortell, J. Smith, and C. Cosco. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus. J. Virol. 70:7783.
23. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
24. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341-3349.
25. Hussell T, U. Khan, and P. Openshaw. 1997. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. J. Immunol. 159:328.
26. Issacs, D., N.B. MacDonald, C.R.M. Bangham, A.J. McMichael, P.O. Higgins, and D.A.J Tyrrell. 1991. The specific cytotoxic T-cell response of adult volunteers to infection with respiratory syncytial virus. Immunol. Infect. Dis. 1:5-12.
27. Jankovic, D., P. Casper, M. Zweig, M. Garcia-Moll, S.D. Showalter, F.R. Vogel, and A. Sher. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159:2409.
28. Jelinek, D.F., and J.K. Braaten. 1995. Role of IL-12 in human B lymphocyte proliferation and differentiation. J. Immunol. 154:1606-1613.
29. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, R.A. Shevdoff, and C.E. Stewart. 1968. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-413.
30. Kakuk, T.J., K. Soike, R.J. Brideau, R.M. Zaya, S.L. Cole, J-Y. Zhang, E.D. Roberts, P.A. Wells, and M.W. Wathen. 1993. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J. Infect. Dis. 167:553-561.
31. Kim, H.W., J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
32. Kim, H.W., S.L. Leikin, J. Arrobio, C.D. Brandt, R.M. Chanock, and R.H. Parrott. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or infection. Pediatr. Res. 10:75-78.
33. Li L., D. Young, S.F. Wolf, and Y.S. Choi. 1996. Interleukin-12 stimulates B cell growth by inducing IFN-gamma. Cell. Immunol. 168:133-140.
34. Mahon, B.P., M.S. Ryan, F. Griffin, and K.H.G. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
35. + T cells. Immunol. Rev. 123:209-229.
36. Muelenaer, P.M., F.W. Henderson, V.G. Hemming, E.E. Walsh, L.J. Anderson, G.A. Prince, and B.R. Murphy. 1991. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J. Infect. Dis. 164:15-21.
37. Murphy, B.R., D.W. Alling, M.H. Snyder, E.E. Walsh, G.A. Prince, R.M. Chanock, V.G. Hemming, W.J. Rodriguez, H.W. Kim, B.S. Graham, and P.P. Wright. 1986. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J. Clin. Microbiol. 24:894-898.
38. Murphy, B.R., S.L. Hall, A.B. Kulkarni, J.E. Crowe, P.L. Collins, M. Connors, R.A. Karron, and R.M Chanock. 1994. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:13-36.
39. Murphy, B.R., G.A. Prince, E.E. Walsh, H.W. Kim, R.H. Parrott, V.G. Hemming, W.J. Rodriguez, and R.M. Chanock. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 24:197-202.
40. Rissoan, M.-C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y.-J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-1186.
41. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279.
42. Schwarze, J., G. Cieslewicz, A. Joetham, T. Ikemura, E. Hamelmann, and E.W. Gelfand. 1999. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162:4207-4211.
43. Scott P., and G. Trinchieri. 1997. IL-12 as an adjuvant for cell-mediated immunity. Sem. Immunol. 9:285.
44. Sigurs, N., R. Bjamason, F. Sigurbergsson, B. Kjellman, and B. Bjorksten. 1995. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 95:500.
45. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421-432.
46. Stott, E.J., and G Taylor. 1985. Respiratory syncytial virus, brief review. Arch. Virol. 84:1-52.
47. Tang, Y.W., and B.S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734.
48. Tang, Y.W., and B.S. Graham. 1997. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 99:2183-2191.
49. Tebbey, P.W., M. Hagen, and G.E. Hancock. 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 188:1967-1972.
50. Tristram, D.A., R.C. Welliver, C.K. Mohar, D.A. Hogerman, S.W. Hildreth, and P. Paradiso. 1993. Immunogenicity and safety of a respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J. Infect. Dis. 167:191-195.
51. Warren, H.S., and Chedid, L.A. 1988. Future prospects for vaccine adjuvants. Crit. Rev. Immunol. 141,1720-1727.
52. Wynn T.A., D. Jankovic, S. Hieny, A.W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701-4709.
53. Yoshimoto, T., H. Okamura, Y.I. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94:3948-3953.